A Clinical Trial to Assess Safety and Pharmacokinetics of Fosnetupitant 235 mg and Metabolites in Healthy Volunteers

Clinical trial NCT06840769 · TERMINATED

Trial details

NCT number: NCT06840769
Sponsor: Helsinn Healthcare SA
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2023-06-17
Primary completion: 2023-10-18
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.